Reshu Agarwal

639 total citations
43 papers, 291 citations indexed

About

Reshu Agarwal is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Reshu Agarwal has authored 43 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 21 papers in Epidemiology and 12 papers in Hepatology. Recurrent topics in Reshu Agarwal's work include SARS-CoV-2 and COVID-19 Research (14 papers), Hepatitis C virus research (10 papers) and COVID-19 Clinical Research Studies (9 papers). Reshu Agarwal is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), Hepatitis C virus research (10 papers) and COVID-19 Clinical Research Studies (9 papers). Reshu Agarwal collaborates with scholars based in India, United Kingdom and Bangladesh. Reshu Agarwal's co-authors include Ekta Gupta, Gagandeep Singh, Immaculata Xess, Arnab Ghosh, Shiv Kumar Sarin, Guresh Kumar, Manoj Kumar, Pratibha Kale, Vibha Mehta and Sheetalnath Rooge and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Reshu Agarwal

35 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reshu Agarwal India 9 186 152 35 31 28 43 291
Daniel Hornuß Germany 9 152 0.8× 58 0.4× 46 1.3× 5 0.2× 63 2.3× 24 359
Matthijs Backx United Kingdom 10 234 1.3× 270 1.8× 8 0.2× 38 1.2× 13 0.5× 27 324
A. Mewis Belgium 10 61 0.3× 100 0.7× 18 0.5× 7 0.2× 39 1.4× 14 253
Keisuke Kamada Japan 11 224 1.2× 138 0.9× 20 0.6× 12 0.4× 34 1.2× 42 304
Miguel Sierra‐Hoffman United States 9 120 0.6× 143 0.9× 3 0.1× 23 0.7× 16 0.6× 22 298
Peter Rath Germany 7 213 1.1× 173 1.1× 6 0.2× 29 0.9× 35 1.3× 13 309
Zahra Abtahian Iran 10 264 1.4× 116 0.8× 8 0.2× 41 1.3× 28 1.0× 27 368
Ramona Liza Tillmann Germany 10 232 1.2× 268 1.8× 16 0.5× 2 0.1× 19 0.7× 15 314
Philip Raj Abraham India 10 107 0.6× 117 0.8× 15 0.4× 8 0.3× 109 3.9× 21 311
Mark Wissel United States 4 352 1.9× 292 1.9× 8 0.2× 68 2.2× 25 0.9× 7 400

Countries citing papers authored by Reshu Agarwal

Since Specialization
Citations

This map shows the geographic impact of Reshu Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshu Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshu Agarwal more than expected).

Fields of papers citing papers by Reshu Agarwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reshu Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshu Agarwal. The network helps show where Reshu Agarwal may publish in the future.

Co-authorship network of co-authors of Reshu Agarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Reshu Agarwal. A scholar is included among the top collaborators of Reshu Agarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reshu Agarwal. Reshu Agarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Samal, Jasmine, Reshu Agarwal, Ekta Gupta, Sheetalnath Rooge, & Akshita Gupta. (2024). Newer Diagnostic Virological Markers for Hepatitis B Virus Infection. Euroasian Journal of Hepato-Gastroenterology. 14(2). 214–220.
3.
4.
Samal, Jasmine, et al.. (2023). The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of a few cases. SHILAP Revista de lepidopterología. 3. 2 indexed citations
5.
Mane, Arati, Reshu Agarwal, Meenu Bajpai, et al.. (2023). Validation of dried blood spot for serological diagnosis of Hepatitis B and C: a multicentric study. Diagnostic Microbiology and Infectious Disease. 108(2). 116108–116108. 1 indexed citations
6.
7.
Maiwall, Rakhi, Bansidhar Tarai, Ekta Gupta, et al.. (2023). Prevalence and Predictors for Respiratory Viral Infections among Liver Disease Patients. Euroasian Journal of Hepato-Gastroenterology. 13(2). 108–114.
8.
Garg, Rahul, Reshu Agarwal, Santanu Das, et al.. (2022). SARS-CoV-2 Lineage Tracking, and Evolving Trends Seen during Three Consecutive Peaks of Infection in Delhi, India: a Clinico-Genomic Study. Microbiology Spectrum. 10(2). e0272921–e0272921. 2 indexed citations
9.
Samal, Jasmine, et al.. (2022). Co-infection of SARS-CoV-2 with other respiratory pathogens in patients with liver disease. Access Microbiology. 4(10). acmi000456–acmi000456. 3 indexed citations
10.
Bajpai, Meenu, Suresh Kumar, Pratibha Kale, et al.. (2022). Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients. Anais da Academia Brasileira de Ciências. 94(4). e20210202–e20210202. 6 indexed citations
11.
Garg, Rahul, et al.. (2022). Evaluation of blood samples collected by dried blood spots (DBS) method for hepatitis B virus DNA quantitation and its stability under real life conditions. SHILAP Revista de lepidopterología. 2(4). 100111–100111. 3 indexed citations
12.
Madan, Taruna, Praveen M. Varghese, Hrishikesh Pandit, et al.. (2021). A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples. American Journal of Respiratory Cell and Molecular Biology. 65(1). 41–53. 31 indexed citations
13.
14.
Gupta, Akshita, et al.. (2021). Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples. Journal of Virological Methods. 298. 114300–114300. 3 indexed citations
15.
Gupta, Ekta, et al.. (2020). Evaluation of the Point of Care Molecular Diagnostic Genedrive HCV ID Kit for the detection of HCV RNA in clinical samples. Epidemiology and Infection. 1–23. 8 indexed citations
16.
Singh, Gagandeep, et al.. (2020). Recalcitrant eumycetoma of the foot: Financial burden a major barrier on the road of recovery. PLoS neglected tropical diseases. 14(8). e0008356–e0008356. 1 indexed citations
17.
Gupta, Ekta, et al.. (2020). Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: A reliable, faster and economical method. PLoS ONE. 15(7). e0236859–e0236859. 36 indexed citations
18.
19.
Agarwal, Reshu, et al.. (2017). Chromoblastomycosis in India: Review of 169 cases. PLoS neglected tropical diseases. 11(8). e0005534–e0005534. 56 indexed citations
20.
Pande, J N, et al.. (2005). EVALUATION OF RISK FACTORS AND PREVALENCE OF DRUG RESISTANT TUBERCULOSIS IN NORTH INDIA. CHEST Journal. 128(4). 404S–404S. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Hornuß Breakdown of academic impact, for papers by Matthijs Backx Breakdown of academic impact, for papers by A. Mewis Breakdown of academic impact, for papers by Keisuke Kamada Breakdown of academic impact, for papers by Miguel Sierra‐Hoffman Breakdown of academic impact, for papers by Peter Rath Breakdown of academic impact, for papers by Zahra Abtahian Breakdown of academic impact, for papers by Ramona Liza Tillmann Breakdown of academic impact, for papers by Philip Raj Abraham Breakdown of academic impact, for papers by Mark Wissel
Rankless by CCL
2026